Total Credits: 2
Our second of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office.
Program Details
This course is available to watch on-demand and receive credit for up to one year from the date of webinar release. There is no live Q&A with faculty associated for this program. Registrants will be notified as new webinars in the series are released.
2.0 credits available until June 3, 2021. View the Accreditation Statement/Credit tab for details. Enjoy two, separate case presentations in this one webinar package.
Case Discussions: Decisions on How to Treat Common Benign Thyroid Disorders
Panelists: Maria Papaleontiou (moderator); Elizabeth N. Pearce, Rebecca S. Sippel, Anne R. Cappola, Cari Meinhold Kitahara and Reese W. Randle
Case Discussions: Decisions on How to Personalize Approach to Thyroid Cancer Diagnosis and Treatment
Panelists: Maria Papaleontiou (moderator); Ramona Dadu, Jennifer E. Rosen, Susan C. Pitt and Mabel M. Ryder
Learning Objectives
Learn more...
Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/.
Who Should Attend
American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).
Maria Papaleontiou, MD is an Assistant Professor of Internal Medicine at the University of Michigan, Division of Metabolism, Endocrinology and Diabetes. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. She is a health services researcher in the field of aging as it pertains to thyroid disorders, including thyroid cancer. She is particularly interested in overtreatment with and misuse of thyroid hormone and their adverse effects in older adults. She is also involved in studies focusing on thyroid cancer outcomes using large cancer registries and surveys. Dr. Papaleontiou is currently funded by a K08 award from the National Institute on Aging. She is active in the American Thyroid Association, the Endocrine Society and the American Association of Clinical Endocrinologists.
Elizabeth N. Pearce, MD is currently a Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition. She received her undergraduate and medical degrees from Harvard and a masters’ degree in epidemiology from the Boston University School of Public Health. She completed her residency in internal medicine at Beth Israel Deaconess Medical Center, and her fellowship in endocrinology at Boston University. Dr. Pearce is the 2018-2019 President of the American Thyroid Association. She also serves as the Regional Coordinator for North America for the Iodine Global Network. She is an Associate Editor at Thyroid and at Endocrine Practice and has served on multiple additional editorial boards, including those for the Journal of Clinical Endocrinology and Metabolism, Clinical Endocrinology, and Lancet Diabetes & Endocrinology. She recently co-chaired the American Thyroid Association’s Thyroid in Pregnancy Guidelines Task Force. Her research interests include the sufficiency of dietary iodine in the U.S., thyroid function in pregnancy, the thyroid effects of environmental perchlorate exposure, and the cardiovascular effects of subclinical thyroid dysfunction. Dr. Pearce was the 2011 recipient of the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland and the 2018 Women in Thyroidology Woman of the Year.
Rebecca S. Sippel, MD, FACS is Professor of Surgery, Chief of the Division of Endocrine Surgery, and Vice Chair of Academic Affairs and Professional Development at the University of Wisconsin. She is a nationally recognized leader in the field of endocrine surgery. She is currently serving as the program director for the Endocrine Surgery Fellowship at the University of Wisconsin. She is past Secretary of the American Association of Endocrine Surgeons and past President of Association for Academic Surgery. She has a highly productive clinical research program focusing on the diagnosis and management of patients with endocrine disorders and the outcomes of patients after surgery. She is currently PI on an R01 funded randomized controlled trial examining the utility of prophylactic central neck dissection for patients with clinically node negative thyroid cancer.
Anne R. Cappola, MD, ScM is a Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism, Director of Clinical Research in the Department of Medicine, and Director of the Center for Human Phenomic Science at the Perelman School of Medicine at the University of Pennsylvania. Dr. Cappola directs an NIH-funded research program on the hormonal alterations that occur with aging and the clinical impact of these changes, including the clinical impact of subclinical thyroid dysfunction in older individuals. Dr. Cappola is a highly productive investigator who has published over 100 research publications. Dr. Cappola is an elected member of the American Society for Clinical Investigation, the American Association of Physicians, and the Interurban Clinical Club and an Associate Editor for JAMA. She has received the Thyroid Clinical Research Mentor Award from the Endocrine Society and the American Thyroid Association’s Van Meter Award.
Cari Meinhold Kitahara, PhD, MS is an Investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, National Institutes of Health. She received an MHS and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Kitahara’s research focuses on the etiology of thyroid cancer and on the potential cancer risks associated with occupational and medical radiation exposure. She is Principal Investigator of the U.S. Radiologic Technologists cohort study and the Hyperthyroid Follow-Up Study (an extension of the original Cooperative Thyrotoxicosis Therapy Follow-up Study assembled in the 1960s). She is the 2019 recipient of the Van Meter Award from the American Thyroid Association and serves on the editorial board of Thyroid. She has authored over 120 peer-reviewed manuscripts.
Reese W. Randle, MD, FACS is the Assistant Professor of Surgery at Wake Forest Baptist Medical Center. He obtained his medical degree from the University of Texas Health Science Center, Houston. As a board-certified general surgeon with additional fellowship training in endocrine surgery, he specializes in treating benign and malignant disease of the thyroid, parathyroid, and adrenal glands. Dr. Randle’s clinical research interests have largely focused on improving the quality and efficiency of endocrine surgery and improving the safety of surgical training. He has training in both quantitative and qualitative research methods and employ both in the study of thyroid cancer. He serves on the governing committee for the Collaborative Endocrine Surgery Quality Improvement Program through the American Association of Endocrine Surgeons (AAES) and is the alternate representative for the AAES to the Commission on Cancer.
Ramona Dadu, MD is an Assistant Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas M.D. Anderson Cancer Center. She completed her research fellowship at Baylor College of Medicine and the UT Texas M.D. Anderson Cancer Center. She is a member of a number of professional societies including the American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists and the American Association of Clinical Oncology. Dr. Dadu is a research grant recipient of the ATA.
Jennifer E. Rosen, MD, FACS is Chief of Endocrine Surgery and Vice Chair for Research of the Department of Surgery at Medstar Washington Hospital Center. Dr. Rosen received her undergraduate degree from the University of Pennsylvania and her medical degree from Thomas Jefferson University Medical College. She then completed her residency training in general surgery at Beth Israel Medical Center before completing her fellowship training in surgical oncology at the National Cancer Institute (NCI). Dr. Rosen specializes in the surgical treatment of diseases of the endocrine glands, including the thyroid, parathyroid and adrenal. In addition to surgical techniques, Dr. Rosen works closely with endocrinologists, nuclear medicine physicians and radiologists in order to determine proper testing as well as the best treatment options for each patient. Her clinical interests include treating patients with complex, advanced or recurrent endocrine disease and improving patient outcomes through the use of clinical studies and tailored treatment. Her research interests include bringing in new technology and tools for diagnosing thyroid nodules as well as discriminating cancerous nodules from benign nodules. Dr. Rosen has previously patented tools that are now being used at MedStar Washington Hospital Center. She is currently interested in improving genetic studies in order to predict thyroid cancer in individuals as well as putting together large national databases to look at what improves survival in patients with thyroid cancer. She serves on the Collaborative Endocrine Surgery Quality Improvement Program Committee of the American Association of Endocrine Surgeons (AAES) and sits as a representative of the College to the Commission on Cancer (COC), a program of the American College of Surgeons (ACS). She has been active on numerous committees of the American Thyroid Association (ATA) and serves as Endocrine Section Editor for the Journal of Surgical Oncology.
Susan C. Pitt, MD, MPHS, FACS is an Assistant Professor of Surgery in the Division of Endocrine Surgery at the University of Wisconsin School of Medicine and Public Health. Her clinical practice includes patients with benign and malignant thyroid, parathyroid, and adrenal disease. Dr. Pitt’s NIH funded health services research focuses on reducing overtreatment of patients with thyroid cancer. Her research team investigates the role of emotions, like fear and anxiety, on treatment decision-making. They also utilize stakeholder engagement and have developed two decision support tools for patients with low-risk thyroid cancer. In addition to her medical degree from the Medical College of Wisconsin, Dr. Pitt has a master’s degree in Population Health Science from Washington University in St. Louis with a concentration in shared decision-making. She completed her residency at Washington University in St. Louis followed by an Endocrine Surgery fellowship at Brigham and Women’s Hospital. She holds national leadership positions in the Association of Academic Surgery and the Association of Women Surgeons and is an active member of the American Association of Endocrine Surgeons (AAES) and the American Thyroid Association. She is also a past recipient of the AAES Paul LoGerfo Research Award.
Mabel M. Ryder, MD is an Endocrinologist and Assistant Professor of Medicine at Mayo Clinic, Rochester. She completed her residency and endocrine fellowship at the University of Cincinnati College of Medicine. Dr. Ryder’s interests are endocrine cancers, thyroid disease and cancer, adrenal disorders and cancer, and the role of tumor microenvironment in facilitating thyroid cancer progressions. She is a member of the American Thyroid Association and International Thyroid Oncology Group.
Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society and the American Thyroid Association. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians.
The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this activity for a maximum of 2.00 AMA PRA Category 1 Credit™ and 2.00 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
As an accredited provider of Continuing Medical Education (CME) by the Accreditation Council for Continuing Medical Education (ACCME), the Endocrine Society is also able to provide Maintenance of Certification (MOC) points through the ABIM MOC Assessment Recognition Program. As such, the Endocrine Society ensures that activities registered by the Society for ABIM MOC recognition meet the requirements for all MOC activities as defined by the American Board of Internal Medicine (ABIM). The Endocrine Society is responsible for submitting participant completion information to ACCME for the purpose of granting ABIM MOC credit.